NeoPHOEBE (BIG 6-11)
Intro text:
Page under construction!
Buparlisib for HER2-positive, PIK3CA wild-type and PIK3CA mutant primary breast cancer
- ClinicalTrials.gov Identifier: NCT01816594
Buparlisib for HER2-positive, PIK3CA wild-type and PIK3CA mutant primary breast cancer